Zelis Owners in Talks to Sell Stake at $17 Billion Value

Bain Capital and Parthenon Capital are in talks to sell a minority stake in Zelis in a transaction that could value the health-care technology company at about $17 billion, people with knowledge of the matter said.

The private equity firms are considering selling a 20% to 25% stake in Zelis, according to the people. Zelis has received preliminary interest from health-insurers, a payments company, buyout firms and sovereign wealth funds, they said.